全文获取类型
收费全文 | 126399篇 |
免费 | 9466篇 |
国内免费 | 3642篇 |
专业分类
耳鼻咽喉 | 987篇 |
儿科学 | 2341篇 |
妇产科学 | 1783篇 |
基础医学 | 7026篇 |
口腔科学 | 2870篇 |
临床医学 | 15214篇 |
内科学 | 18886篇 |
皮肤病学 | 2309篇 |
神经病学 | 6557篇 |
特种医学 | 4074篇 |
外国民族医学 | 39篇 |
外科学 | 12392篇 |
综合类 | 18685篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5292篇 |
眼科学 | 2048篇 |
药学 | 10220篇 |
80篇 | |
中国医学 | 11183篇 |
肿瘤学 | 17496篇 |
出版年
2024年 | 316篇 |
2023年 | 2244篇 |
2022年 | 4114篇 |
2021年 | 5548篇 |
2020年 | 5199篇 |
2019年 | 4641篇 |
2018年 | 4392篇 |
2017年 | 4862篇 |
2016年 | 5169篇 |
2015年 | 4947篇 |
2014年 | 8960篇 |
2013年 | 11350篇 |
2012年 | 7358篇 |
2011年 | 7871篇 |
2010年 | 6523篇 |
2009年 | 5980篇 |
2008年 | 5846篇 |
2007年 | 6289篇 |
2006年 | 5625篇 |
2005年 | 5012篇 |
2004年 | 4057篇 |
2003年 | 3701篇 |
2002年 | 3027篇 |
2001年 | 2673篇 |
2000年 | 2238篇 |
1999年 | 1772篇 |
1998年 | 1445篇 |
1997年 | 1233篇 |
1996年 | 1009篇 |
1995年 | 906篇 |
1994年 | 714篇 |
1993年 | 549篇 |
1992年 | 497篇 |
1991年 | 446篇 |
1990年 | 385篇 |
1989年 | 332篇 |
1988年 | 321篇 |
1987年 | 274篇 |
1986年 | 216篇 |
1985年 | 254篇 |
1984年 | 223篇 |
1983年 | 166篇 |
1982年 | 164篇 |
1981年 | 163篇 |
1980年 | 129篇 |
1979年 | 121篇 |
1978年 | 65篇 |
1977年 | 43篇 |
1976年 | 49篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
61.
Abstract End-stage liver disease caused by the hepatitis C virus is a major indication for liver transplantation. However, recurrence of hepatitis in the graft is a major issue. HCV re-infection after transplantation is almost constant, and recent data confirm that it significantly impairs patient and graft survival. Factors that may influence disease severity and consequent progression of HCV graft injury remain unclear. Chronic HCV infection develops in 60%–80% of patients, and 6%–28% ultimately progress to cirrhosis within 5 years. Pre-transplantation antiviral treatment is not easily related to poor tolerance. Attempts to administer prophylactic post-transplantation antiviral treatment are under evaluation but are limited by antiviral drug side effects. Treatment of established graft lesions with interferon or ribavirin as single agents has been disappointing. Combination therapy gave promising results, with sustained virological response in 25% of patients, but indications, modality and duration of treatment should be assessed. 相似文献
62.
浅谈基因治疗的现状及其面临的困境 总被引:1,自引:0,他引:1
基因治疗将在未来的疾病治疗中扮演重要的角色,然而这一新颖的技术却面临着诸多问题,本文论述了基因治疗的发展现状及其所面临的技术难题。 相似文献
63.
64.
65.
Uta Lichter-Konecki Christian Benninger Werner E. Brandeis Peter Matthis Dieter Scheffner 《Pediatric hematology and oncology》1987,4(1):77-85
Thirteen children with acute lymphoblastic leukemia (ALL) were investigated before and during cytotoxic therapy. EEG findings were correlated with the clinical course and the therapy protocol and compared with normal data obtained from 295 healthy children. Frequency analysis of the background activity of the EEG revealed an initial slowing of the background activity prior to therapy and further slowing each time a combination of vincristine (VCR), daunorubicine (DAU) or adriblastine (ADR), prednisone (FRED), and L-asparaginase (L-ASP) was administered. The slowing of the background activity correlated only with the administration of these drugs. DAU, ADR, and FRED are not known to influence the EEG; therefore, VCR and L-ASP remain the primary candidates responsible for the central nervous system alteration. 相似文献
66.
采用 TAD 方案治疗急性非淋巴细胞性白血病(ANLL)12例,年龄17~47岁。总有效率为66.7%,完全缓解率(CR)为41.7%。5例获 CR 的时间是26~66天,平均53天,较国内其它方案为快。CR 时间为2~9月,平均6.2月,较其它方案又较短。TAD 方案对心脏的毒性作用轻微。TAD 方案对5例获 CR 者,于诱导治疗第一疗程后,除1例外,骨髓中白血病细胞百分比下降均不明显;但于第二疗程后,白血病细胞全部减少到骨髓有核细胞总数的20%/以下,这种现象似可作为本方案预后的观察指标。 相似文献
67.
应重视口腔颌面部恶性肿瘤的综合序列治疗 总被引:11,自引:2,他引:9
口腔颌面部恶性肿瘤约占全身恶性肿瘤的3%,虽然所占比例不高,但l大l其解剖部位特殊.涉及美观和重要的生理功能,冈此对患者机体和心理的影响不容忽视。早期(Ⅰ、Ⅱ期)口腔颌面部恶性肿瘤无论采用手术和(或)放射治疗,均能取得良好效果。但遗憾的是,大多数患者就诊时,已属局部一区域晚期(Ⅲ、Ⅳ期)。由于受到局部解剖和维持功能的限制,单纯通过扩大手术切除范围和改进现有手术技术,除能改善患者生存质量外,已无法提高此类患者的生存率,延长其生存时间。 相似文献
68.
W.-S. Ahn D.-J. Kim† G.-T. Chae‡ J.-M. Lee S.-M. Bae§ J.-I. Sin§ Y.-W. Kim§ S.-E. Namkoong & I. P. Lee 《International journal of gynecological cancer》2004,14(4):589-594
A mushroom extract, Agaricus blazei Murill Kyowa (ABMK), has been reported to possess antimutagenic and antitumor effects. Here, we investigate the beneficial effects of ABMK consumption on immunological status and qualities of life in cancer patients undergoing chemotherapy. One hundred cervical, ovarian, and endometrial cancer patients were treated either with carboplatin (300 mg / m(2)) plus VP16 (etoposide, 100 mg / m(2)) or with carboplatin (300 mg / m(2)) plus taxol (175 mg / m(2)) every 3 weeks for at least three cycles with or without oral consumption of ABMK. We observed that natural killer cell activity was significantly higher in ABMK-treated group (ANOVA, n = 39, P < 0.002) as compared with nontreated placebo group (n = 61). However, no significant difference in lymphokine-activated killer and monocyte activities was observed in a manner similar to the count of specific immune cell populations between ABMK-treated and nontreated groups. However, chemotherapy-associated side effects such as appetite, alopecia, emotional stability, and general weakness were all improved by ABMK treatment. Taken together, this suggests that ABMK treatment might be beneficial for gynecological cancer patients undergoing chemotherapy. 相似文献
69.
70.
Many new insights have been gained over the past 5 years into the mechanisms that regulate immune reactivity to cell and organ transplants. This new knowledge is being applied to the development of innovative experimental strategies that may soon be evaluated in the clinic. 相似文献